EurekaMag
+ Translate
+ Most Popular
The pigeon tick (Argas reflexus): its biology, ecology, and epidemiological aspects
Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)
Lipogranuloma: a preventable complication of dacryocystorhinostomy
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
Bees from the Belgian Congo. The acraensis group of Anthophora
Placing gingival retraction cord
Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children
Acariens plumicoles Analgesoidea parasites des oiseaux du Maroc
Injuries of terminal phalanges of the fingers in children
Biology of flowering and nectar production in pear (Pyrus communis)
Das Reliktvorkommen der Aspisviper (Vipera aspis L.) im Schwarzwald
Hydrological modelling of drained blanket peatland
Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary artery. General review and autopsy analysis of 30 cases
Cyto genetic analyses of lymphocyte cultures after exposure to calcium cyclamate
Axelrodia riesei, a new characoid fish from Upper Rio Meta in Colombia With remarks concerning the genus Axelrodia and description of a similar, sympatric, Hyphessobrycon-species
Favorable evolution of a case of tuberculosis of pancreas under antibiotic action
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3
Parenteral microemulsions: an overview
Temperate pasture: management for grazing and conservation
Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation
Thermal expansion and cracking of three confined water-saturated igneous rocks to 800C
Revision of the genera of the tribe Stigmoderini (Coleoptera: Buprestidae) a discussion of phylogenetic relationships
Anal tuberculosis. Report of a case
Gastric tuberculosis in the past and present
Adaptive responses of the cardiovascular system to prolonged spaceflight conditions: assessment with Holter monitoring

Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children


Efficacy and safety of Saccharomyces boulardii in amebiasis-associated diarrhea in children



Turkish Journal of Pediatrics 51(3): 220-224



ISSN/ISBN: 0041-4301

PMID: 19817264

The efficacy and safety of adding Saccharomyces boulardii to antibiotic treatment for amebiasis-associated acute diarrhea in children were assessed in this study. Forty-five children in Group I received only metronidazole per oral for 10 days while 40 patients in Group II received S. boulardii in addition to the same medication. The major outcomes investigated were duration of acute and bloody diarrhea, frequency and consistency of stools, resolution time of the symptoms, and the tolerance and side effects of the treatment regimens. The median duration of acute diarrhea was 5 (1-10) days in Group I and 4.5 (1-10) days in Group II (p=0.965). The median number of stools on follow-up and duration of bloody diarrhea, fever, abdominal pain and vomiting were similar in the two groups. S. boulardii was well tolerated by the children and no side effects were recorded. Addition of S. boulardii to antibiotic treatment of amebiasis-associated acute diarrhea in children does not seem to be more effective than metronidazole treatment alone.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 052895157

Download citation: RISBibTeXText

Related references

Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. American Journal of Tropical Medicine and Hygiene 80(6): 953-955, 2009

Efficacy and safety of Saccharomyces boulardii for acute diarrhea. Pediatrics 134(1): E176-E191, 2014

Efficacité de Saccharomyces boulardii dans le traitement des diarrhées du SIDA - Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS patients. Annales de Medecine Interne (Paris) 142(1): 64-65, 1991

Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised controlled trial. Indian Journal of Pediatrics 79(4): 478-482, 2012

Efficacy and Safety of Saccharomyces boulardii in Acute Rotavirus Diarrhea: Double Blind Randomized Controlled Trial from a Developing Country. Journal of Tropical Pediatrics 62(6): 464-470, 2016

Traitement des diarrhées aiguës infantiles: essai contrôlé de Saccharomyces boulardii - Treatment of acute diarrhea in infants a controled trial of Saccharomyces boulardii. Annales de Pediatrie (Paris) 32(6): 561-563, 1985

Comparison of efficacy of Saccharomyces boulardii strain in the treatment of acute diarrhea in children: A prospective, single-blind, randomized controlled clinical trial. Journal of Pharmacology and Pharmacotherapeutics 4(3): 205-208, 2013

Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study. American Journal of Tropical Medicine and Hygiene 82(3): 488-491, 2010

Contribution d'une biotherapeutique (saccharomyces boulardii): Associee a la rehydratation par voie orale: Dans le traitement des diarrhees aigues de l'enfant - Use of saccharomyces boulardii in the treatment of infant acute diarrhea. Medecine d'Afrique Noire 50(11): 477-479, 2003

Comparison of safety, effectiveness and serum inflammatory factor indexes of Saccharomyces boulardii versus Bifidobacterium triple viable in treating children with chronic diarrhea: a randomized trial. Translational Pediatrics 10(6): 1677-1685, 2021

Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Annales de Medecine Interne 142(1): 64-65, 1991

Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opinion on Biological Therapy 12(4): 395-410, 2012

Diarrhées en relation avec le SIDA : essai en double aveugle de Saccharomyces boulardii - AIDS-related diarrhea: a double-blind trial of Saccharomyces boulardii. la Semaine des Hopitaux de Paris 71(23-24): 735-741, 1995

Therapeutical evaluation of saccharomyces boulardii in children with acute diarrhea. Compendium de Investigaciones Clinicas Latinoamericanas 9(3): 108-112, 1989

Multivariate analysis of the clinical efficacy of a biotherapeutic agent, Saccharomyces boulardii, for the prevention of antibiotic-associated diarrhea. American Journal of Epidemiology 138(8): 649, 1993